23 results
8-K
EX-99.1
PDSB
PDS Biotechnology Corporation
20 Sep 23
PDS Biotech Announces PDS0202 Elicits Active Neutralization of Multiple Influenza Strains in Preclinical Studies
4:10pm
reactive antibody profile due to humans having broader exposure to influenza and thus the recall of a more diverse population of memory B cells than
8-K
EX-1.1
PDSB
PDS Biotechnology Corporation
17 Jun 21
PDS Biotech Announces Proposed Offering of Common Stock
12:00am
voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement
424B4
mmv3f r74w
12 Feb 20
Prospectus supplement with pricing info
5:22pm
424B3
m259t4lsctnq3j
29 Aug 19
Prospectus supplement
4:08pm
424B3
t4qv3vzge myvj
15 Feb 19
Prospectus supplement
12:00am
S-4/A
7w16ojt
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
EX-10.24
1htzd9d7dx9hj7
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4
r3kupqabmpq ph
20 Dec 18
Registration of securities issued in business combination transactions
9:56pm